Factors Identified That Predict Glycemia Trajectory in Type 2 Diabetes ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Can't see the images? View as webpage.
 
To ensure that you never miss an issue, please whitelist us.
DIABETES IN CONTROL | News and Information for Medical Professionals
DIC_23Years_Badge.png
     

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D
A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical history significant for type 2 diabetes, hypertension, dyslipidemia, and obesity. When asked about his priorities for care, he desired to decrease the frequency of his hypoglycemic events and to lose weight. The patient reports blood glucose readings ranging from 52-65 mg/dL two or three times weekly with pronounced rebound hyperglycemia. He had a private insurance plan with low copays. His current A1C was 7.9%. He weighed 240 pounds and had a BMI of 34.4 kg/m2. Read more to learn medication regimen, recommendations, and lessons learned. 
Read More

Factors Identified That Predict Glycemia Trajectory in Type 2 Diabetes

Researchers extracted data covering primary and specialized health care for 9,631 patients with type 2 diabetes. Six-year hemoglobin A1c (HbA1c) trajectories were examined. To predict trajectory membership, a linear discriminant analysis and neural networks were applied.
Learn More
Factors Identified That Predict Glycemia Trajectory in Type 2 Diabetes

Regular, Short Breaks From Sitting Aid Cardiometabolic Markers
Regular, Short Breaks From Sitting Aid Cardiometabolic Markers

Colleagues examined the acute effects of multiple doses of a sedentary break intervention (light-intensity walking) on cardiometabolic risk factors. Eleven middle- and older-aged adults completed eight-hour conditions on five separate days, including one uninterrupted sedentary (control) condition and four acute (experimental) trials that entailed different sedentary break frequency/duration combinations. 
Read More

     

  dic_icon_facebook  dic_icon_twitter   dic_icon_linkedIn

©2022 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control

2093 Philadelphia Pike #8370
Claymont, DE 19703

DiabetesInControl.com | Contact Us |  Update Profile | Unsubscribe